ANAVEX LIFE SCIENCES CORP. Basic Shares Outstanding (Weighted Average)
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Basic Shares Outstanding (Weighted Average) of 92.70 billion shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 92.70B shares, a 8.57% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 92.68M shares, a 8.94% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 89.03M shares, a 4.98% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was -254.92B shares, a 300690.30% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic for fiscal 2025 was 85.29M shares, a 2.18% increase from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic for fiscal 2024 was 83.47M shares, a 4.61% increase from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic for fiscal 2023 was 79.79M shares, a 3.74% increase from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. weighted average number of shares outstanding, basic for fiscal 2022 was 76.91M shares, a 10.18% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 92.70B shares 10-Q · filed 2026-08-28 | 46.39B shares derived: average of 2 quarters · filed 2026-08-28 | 91.45B shares 10-Q · filed 2026-08-28 | -40.51B shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | 92.68M shares 10-Q · filed 2026-08-28 | 90.83M shares 10-Q · filed 2026-08-28 | -84.91B shares derived: average of 3 quarters · filed 2026-08-28 | -42.34B shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | 89.03M shares 10-Q · filed 2026-02-09 | -127.41B shares derived: average of 2 quarters · filed 2026-08-28 | -56.48B shares derived: average of 3 quarters · filed 2026-08-28 | -42.34B shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | -254.92B shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -84.77B shares derived: average of 2 quarters · filed 2026-08-28 | -56.48B shares derived: average of 3 quarters · filed 2026-08-28 | 85.29M shares 10-K/A · filed 2026-08-28 | ||||
| 2025-06-30 | 85.38B shares 10-Q · filed 2026-08-28 | 85.38M shares 10-Q · filed 2025-08-12 | 42.73B shares derived: average of 2 quarters · filed 2026-08-28 | 85.09B shares 10-Q · filed 2026-08-28 | 85.09M shares 10-Q · filed 2025-08-12 | 21.41B shares derived: average of 4 quarters · filed 2026-08-28 | ||
| 2025-03-31 | 85.07M shares 10-Q · filed 2026-08-28 | 84.94M shares 10-Q · filed 2026-08-28 | 84.89M shares derived: average of 3 quarters · filed 2026-08-28 | 84.81M shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | 84.81M shares 10-Q · filed 2026-02-09 | 84.81M shares derived: average of 2 quarters · filed 2026-08-28 | 84.72M shares derived: average of 3 quarters · filed 2026-08-28 | 84.15M shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2024-09-30 | 84.81M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | 84.67M shares derived: average of 2 quarters · filed 2026-08-28 | 83.93M shares derived: average of 3 quarters · filed 2026-08-28 | 83.47M shares 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | 84.54M shares 10-Q · filed 2025-08-12 | 83.50M shares derived: average of 2 quarters · filed 2025-08-12 | 83.02M shares 10-Q · filed 2025-08-12 | 82.77M shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2024-03-31 | 82.46M shares 10-Q · filed 2025-05-13 | 82.27M shares 10-Q · filed 2025-05-13 | 82.18M shares derived: average of 3 quarters · filed 2026-08-28 | 81.85M shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2023-12-31 | 82.08M shares 10-Q · filed 2025-02-12 | 82.04M shares derived: average of 2 quarters · filed 2026-08-28 | 81.65M shares derived: average of 3 quarters · filed 2026-08-28 | 80.81M shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2023-09-30 | 82.00M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | 81.44M shares derived: average of 2 quarters · filed 2026-08-28 | 80.39M shares derived: average of 3 quarters · filed 2026-08-28 | 79.79M shares 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | 80.88M shares 10-Q · filed 2024-08-06 | 79.59M shares derived: average of 2 quarters · filed 2024-08-06 | 79.05M shares 10-Q · filed 2024-08-06 | |||||
| 2023-03-31 | 78.30M shares 10-Q · filed 2024-05-09 | 78.14M shares 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | 77.98M shares 10-Q · filed 2024-02-07 | |||||||
| 2022-09-30 | 76.91M shares 10-K · filed 2023-11-27 | |||||||
| 2021-09-30 | 69.80M shares 10-K · filed 2023-11-27 | |||||||
| 2017-03-31 | 41.16M shares 10-Q · filed 2017-05-10 | 39.76M shares 10-Q · filed 2017-05-10 | 38.43M shares derived: average of 3 quarters · filed 2017-05-10 | 37.75M shares derived: average of 4 quarters · filed 2017-05-10 | ||||
| 2016-12-31 | 38.39M shares 10-Q · filed 2017-02-07 | 37.06M shares derived: average of 2 quarters · filed 2017-02-07 | 36.61M shares derived: average of 3 quarters · filed 2017-02-07 | 36.26M shares derived: average of 4 quarters · filed 2017-05-10 | ||||
| 2016-09-30 | 35.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | 35.72M shares derived: average of 2 quarters · filed 2016-12-14 | 35.55M shares derived: average of 3 quarters · filed 2017-05-10 | 35.15M shares 10-K · filed 2016-12-14 | ||||
| 2016-06-30 | 35.71M shares 10-Q · filed 2016-08-11 | 35.46M shares derived: average of 2 quarters · filed 2017-05-10 | 34.96M shares 10-Q · filed 2016-08-11 | 33.23M shares derived: average of 4 quarters · filed 2017-05-10 | ||||
| 2016-03-31 | 35.21M shares 10-Q · filed 2017-05-10 | 34.59M shares 10-Q · filed 2017-05-10 | 32.40M shares derived: average of 3 quarters · filed 2017-05-10 | 29.08M shares derived: average of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | 33.97M shares 10-Q · filed 2017-02-07 | 31.00M shares derived: average of 2 quarters · filed 2017-02-07 | 27.03M shares derived: average of 3 quarters · filed 2017-02-07 | 23.85M shares derived: average of 4 quarters · filed 2017-02-07 | ||||
| 2015-09-30 | 28.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | 23.56M shares derived: average of 2 quarters · filed 2016-12-14 | 20.48M shares derived: average of 3 quarters · filed 2016-12-14 | 18.58M shares 10-K · filed 2016-12-14 | ||||
| 2015-06-30 | 19.10M shares 10-Q · filed 2016-08-11 | 76.38M shares 10-Q · filed 2015-08-14 | 16.71M shares derived: average of 2 quarters · filed 2016-08-11 | 15.44M shares 10-Q · filed 2016-08-11 | 61.75M shares 10-Q · filed 2015-08-14 | -7.28M shares derived: average of 4 quarters · filed 2016-12-14 | ||
| 2015-03-31 | 14.33M shares 10-Q · filed 2016-05-11 | 57.31M shares 10-Q · filed 2015-05-14 | 13.61M shares 10-Q · filed 2016-05-11 | 54.44M shares 10-Q · filed 2015-05-14 | -16.07M shares derived: average of 3 quarters · filed 2016-12-14 | -2.24M shares derived: average of 4 quarters · filed 2016-12-14 | ||
| 2014-12-31 | 12.91M shares 10-Q · filed 2016-02-08 | 51.63M shares 10-Q · filed 2015-02-17 | -31.26M shares derived: average of 2 quarters · filed 2016-12-14 | -7.76M shares derived: average of 3 quarters · filed 2016-12-14 | 3.65M shares derived: average of 4 quarters · filed 2016-12-14 | |||
| 2014-09-30 | -75.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | -18.09M shares derived: average of 2 quarters · filed 2016-12-14 | 568.25K shares derived: average of 3 quarters · filed 2016-12-14 | 9.80M shares 10-K · filed 2016-12-14 | 39.73M shares 10-K · filed 2014-12-29 | |||
| 2014-06-30 | 39.26M shares 10-Q · filed 2015-08-14 | 38.57M shares derived: average of 2 quarters · filed 2015-08-14 | 38.22M shares 10-Q · filed 2015-08-14 | 37.88M shares derived: average of 4 quarters · filed 2015-08-14 | ||||
| 2014-03-31 | 37.88M shares 10-Q · filed 2015-05-14 | 37.68M shares 10-Q · filed 2015-05-14 | 37.43M shares derived: average of 3 quarters · filed 2015-05-14 | 35.63M shares derived: average of 4 quarters · filed 2015-05-14 | ||||
| 2013-12-31 | 37.48M shares 10-Q · filed 2015-02-17 | 37.20M shares derived: average of 2 quarters · filed 2015-02-17 | 34.88M shares derived: average of 3 quarters · filed 2015-02-17 | 33.72M shares derived: average of 4 quarters · filed 2015-02-17 | ||||
| 2013-09-30 | 36.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | 33.58M shares derived: average of 2 quarters · filed 2014-12-29 | 32.46M shares derived: average of 3 quarters · filed 2014-12-29 | 31.91M shares 10-K · filed 2014-12-29 | ||||
| 2013-06-30 | 30.24M shares 10-Q · filed 2014-08-13 | 30.24M shares derived: average of 2 quarters · filed 2014-08-13 | 30.24M shares 10-Q · filed 2014-08-13 | |||||
| 2013-03-31 | 30.24M shares 10-Q/A · filed 2014-05-30 | 30.24M shares 10-Q/A · filed 2014-05-30 | ||||||
| 2012-12-31 | 30.24M shares 10-Q · filed 2014-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |